Significant Shareholder Dipan Patel Sells $86M in Amneal Pharmaceuticals Stock

summarizeSummary

Dipan Patel, a significant individual shareholder, reported selling approximately $86 million worth of Amneal Pharmaceuticals Class A Common Stock between November 2024 and December 2025, reducing his stake to 5.4%.

check_boxKey Events

• Significant Shareholder Sells Shares

  Dipan Patel, a significant individual shareholder, sold 6,924,729 shares of Class A Common Stock through trusts he controls.

• Substantial Transaction Value

  The sales occurred between November 14, 2024, and December 31, 2025, at prices ranging from $7.74 to $12.42 per share, totaling an estimated maximum value of approximately $86 million.

• Reduced Ownership Stake

  Following these transactions, Dipan Patel's beneficial ownership in Amneal Pharmaceuticals decreased to 16,904,263 shares, representing 5.4% of the outstanding Class A Common Stock.

• Timing Amidst Profitability

  These sales took place during a period when Amneal Pharmaceuticals reported a return to net profitability in its fiscal year 2025, as highlighted in recent SEC filings.

auto_awesomeAnalysis

This Schedule 13D/A filing reveals a substantial reduction in beneficial ownership by Dipan Patel, a significant individual shareholder, who sold nearly 6.9 million shares over a 14-month period. The estimated maximum value of these sales, approximately $86 million, represents over 2% of the company's market capitalization. While the company recently reported a return to profitability in its FY25 10-K, these sales occurred during that period, potentially signaling profit-taking or a reduction in long-term conviction by a key individual. Investors should monitor future ownership changes and the company's performance.